Literature DB >> 8140494

Detection of Chlamydia trachomatis in first catch urine samples from symptomatic and asymptomatic males.

J Moncada1, J Schachter, M A Shafer, E Williams, L Gourlay, B Lavin, G Bolan.   

Abstract

BACKGROUND AND OBJECTIVES: Non-invasive tests are needed to detect Chlamydia trachomatis in the genital tract. For men, urine appears to be a useful specimen for chlamydial antigen or nucleic acid detection. GOAL OF THIS STUDY: To evaluate enzyme immunoassays (EIA) for chlamydial antigens in first catch urine (FCU) from symptomatic and asymptomatic men. STUDY
DESIGN: We conducted five different studies; FCUs and urethral swabs were collected from 1,341 symptomatic and 816 asymptomatic males. Four EIAs (SureCell, Chlamydiazyme, MicroTrak and IDEIA) were tested on the FCU sediments.
RESULTS: Prevalence of chlamydia by tissue culture isolation was 6% for asymptomatic and 14% for symptomatic men. With symptomatic males, the EIA sensitivities and specificities were: SureCell 85% and 97%, IDEIA 82% and 98%, MicroTrak 86% and 99%, and Chlamydiazyme 91% and 95%. For asymptomatic men, Chlamydiazyme sensitivity was 35% with frozen urine vs 77% with fresh urine. Overall, tissue culture sensitivity was about 90%.
CONCLUSION: EIA results on FCU sediments are comparable to that of tissue culture isolation on urethral swabs. In many settings, FCU may be the specimen of choice for diagnosing chlamydial infections in men.

Entities:  

Mesh:

Year:  1994        PMID: 8140494     DOI: 10.1097/00007435-199401000-00003

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  9 in total

1.  Rapid screening and treatment for sexually transmitted diseases in arrestees: a feasible control measure.

Authors:  J F Beltrami; D A Cohen; J T Hamrick; T A Farley
Journal:  Am J Public Health       Date:  1997-09       Impact factor: 9.308

2.  Is urine leukocyte esterase test a useful screening method to predict Chlamydia trachomatis infection in women?

Authors:  J M Chow; J Moncada; D Brooks; G Bolan; H Shaw; J Schachter
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  Impact of reference standard sensitivity on accuracy of rapid antigen detection assays and a leukocyte esterase dipstick for diagnosis of Chlamydia trachomatis infection in first-void urine specimens from men.

Authors:  M Chernesky; D Jang; J Krepel; J Sellors; J Mahony
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

4.  Evaluation of the Vidas Chlamydia test to detect and verify Chlamydia trachomatis in urogenital specimens.

Authors:  J Schachter; R B Jones; R C Butler; B Rice; D Brooks; B Van der Pol; M Gray; J Moncada
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

5.  Ability of new APTIMA CT and APTIMA GC assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in male urine and urethral swabs.

Authors:  M A Chernesky; D H Martin; E W Hook; D Willis; J Jordan; S Wang; J R Lane; D Fuller; J Schachter
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

Review 6.  Current methods of laboratory diagnosis of Chlamydia trachomatis infections.

Authors:  C M Black
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

7.  Detection of Chlamydia trachomatis in urine samples by nucleic acid tests: comparison with culture and enzyme immunoassay of genital swab specimens.

Authors:  S Schepetiuk; T Kok; L Martin; R Waddell; G Higgins
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

8.  Diagnosis of Chlamydia trachomatis infections in asymptomatic men and women by PCR assay.

Authors:  B Toye; R W Peeling; P Jessamine; P Claman; I Gemmill
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

9.  Polymerase chain reaction assay with urine specimens in the diagnosis of acute chlamydia trachomatis infection in women.

Authors:  R Pasternack; A Mustila; P Vuorinen; P K Heinonen; A Miettinen
Journal:  Infect Dis Obstet Gynecol       Date:  1996
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.